Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation
- 1 July 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 320 (1) , 70-75
- https://doi.org/10.1016/j.bbrc.2004.05.134
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and TherapyJournal of Clinical Oncology, 2002
- A reevaluation of integrins as regulators of angiogenesisNature Medicine, 2002
- Angiogenesis inhibitors in clinical development for lung cancerSeminars in Oncology, 2002
- FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibitionTrends in Pharmacological Sciences, 2001
- Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasisOncogene, 2000
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Angiogenesis.Journal of Biological Chemistry, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992